This flaw might yield false negative results in samples harbouring pathogenic indels: in our previous study, tumour sequencing of one ovarian cancer patient failed to identify a germline pathogenic BRCA2 deletion at a homopolymeric region. The gene discussed is BRCA2; the disease is ovarian carcinoma.